Nonhydrolyzable phosphotyrosyl mimetics for the preparation of phosphatase-resistant SH2 domain inhibitors. 1994

T R Burke, and M S Smyth, and A Otaka, and M Nomizu, and P P Roller, and G Wolf, and R Case, and S E Shoelson
Laboratory of Medicinal Chemistry, NCI, National Institutes of Health, Bethesda, Maryland 20892.

Src homology 2 (SH2) domains participate in protein tyrosine kinase (PTK)-mediated cellular signal transduction through their ability to bind with high affinity to phosphotyrosyl (pTyr)-bearing protein sequences. Although peptides containing pTyr competitively inhibit the binding between phosphoproteins and cognate SH2 proteins in a sequence-specific manner, such peptides are rapidly dephosphorylated by cellular phosphatases. We now describe our efforts to develop SH2 inhibitory peptides containing phosphatase-resistant pTyr surrogates. The parent compound, (phosphonomethyl)phenylalanine (Pmp), is a phosphonate-based mimetic of pTyr in which the phosphate ester oxygen (> COPO3H2) has been replaced by a methylene unit (> CCX2PO3H2, X2 = H2). Pmp analogues bearing fluorine (X2 = H, F or X2 = F2) or hydroxyl (X2 = H, OH) substituents on the phosphonate alpha-methylene carbon have been prepared and incorporated into peptides for use as SH2 domain inhibitors. In an assay using the C-terminal SH2 domain of phosphatidylinositol (PI) 3-kinase, peptides having a GXVPML sequence [where X = pTyr, Pmp, hydroxy-Pmp (HPmp), monofluoro-Pmp (FPmp), and difluoro-Pmp (F2Pmp)] exhibited binding potency in the order HPmp < Pmp < FPmp < F2Pmp = pTyr. Distinct peptide sequences which bind selectively with Src and Grb2 SH2 domains were also prepared with pTyr and F2Pmp. The F2Pmp peptides bound with high (0.2- to 5-fold) relative affinity, compared to analogous pTyr peptides. We conclude that peptides containing F2Pmp bind to SH2 domains with high affinity and specificity and, being resistant to cellular phosphatases, should provide a generally useful tool for disrupting SH2 domain-mediated signaling pathways in intact cells.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010649 Phenylalanine An essential aromatic amino acid that is a precursor of MELANIN; DOPAMINE; noradrenalin (NOREPINEPHRINE), and THYROXINE. Endorphenyl,L-Phenylalanine,Phenylalanine, L-Isomer,L-Isomer Phenylalanine,Phenylalanine, L Isomer
D010744 Phosphoric Monoester Hydrolases A group of hydrolases which catalyze the hydrolysis of monophosphoric esters with the production of one mole of orthophosphate. Phosphatase,Phosphatases,Phosphohydrolase,Phosphohydrolases,Phosphomonoesterase,Phosphomonoesterases,Phosphoric Monoester Hydrolase,Hydrolase, Phosphoric Monoester,Hydrolases, Phosphoric Monoester,Monoester Hydrolase, Phosphoric
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006868 Hydrolysis The process of cleaving a chemical compound by the addition of a molecule of water.
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D014443 Tyrosine A non-essential amino acid. In animals it is synthesized from PHENYLALANINE. It is also the precursor of EPINEPHRINE; THYROID HORMONES; and melanin. L-Tyrosine,Tyrosine, L-isomer,para-Tyrosine,L Tyrosine,Tyrosine, L isomer,para Tyrosine
D015688 Oncogene Protein pp60(v-src) A tyrosine-specific protein kinase encoded by the v-src oncogene of ROUS SARCOMA VIRUS. The transforming activity of pp60(v-src) depends on both the lack of a critical carboxy-terminal tyrosine phosphorylation site at position 527, and the attachment of pp60(v-src) to the plasma membrane which is accomplished by myristylation of its N-terminal glycine. Oncogene Protein pp60(src),pp60(v-src),src Oncogene Protein pp60,v-src Protein pp60,Avian Sarcoma Virus-Transforming Protein,Oncogene Protein src,Phosphoprotein pp60(v-src),Rous Sarcoma Virus-Transforming Protein pp60(v-src),p60(v-src),pp60 v-src,src Oncogene Product pp60,v-src Protein,Avian Sarcoma Virus Transforming Protein,Protein pp60, v-src,Protein src, Oncogene,pp60 v src,pp60, v-src Protein,src, Oncogene Protein,v src Protein,v src Protein pp60,v-src, pp60
D019000 Phosphotyrosine An amino acid that occurs in endogenous proteins. Tyrosine phosphorylation and dephosphorylation plays a role in cellular signal transduction and possibly in cell growth control and carcinogenesis. Tyrosine-O-phosphate,Tyrosine O phosphate

Related Publications

T R Burke, and M S Smyth, and A Otaka, and M Nomizu, and P P Roller, and G Wolf, and R Case, and S E Shoelson
February 1999, Bioorganic & medicinal chemistry letters,
T R Burke, and M S Smyth, and A Otaka, and M Nomizu, and P P Roller, and G Wolf, and R Case, and S E Shoelson
April 1995, Journal of medicinal chemistry,
T R Burke, and M S Smyth, and A Otaka, and M Nomizu, and P P Roller, and G Wolf, and R Case, and S E Shoelson
February 2006, Organic & biomolecular chemistry,
T R Burke, and M S Smyth, and A Otaka, and M Nomizu, and P P Roller, and G Wolf, and R Case, and S E Shoelson
February 2005, Journal of medicinal chemistry,
T R Burke, and M S Smyth, and A Otaka, and M Nomizu, and P P Roller, and G Wolf, and R Case, and S E Shoelson
June 2003, Accounts of chemical research,
T R Burke, and M S Smyth, and A Otaka, and M Nomizu, and P P Roller, and G Wolf, and R Case, and S E Shoelson
October 1992, Biochemistry,
T R Burke, and M S Smyth, and A Otaka, and M Nomizu, and P P Roller, and G Wolf, and R Case, and S E Shoelson
March 2003, Protein engineering,
T R Burke, and M S Smyth, and A Otaka, and M Nomizu, and P P Roller, and G Wolf, and R Case, and S E Shoelson
October 2002, Bioorganic & medicinal chemistry letters,
T R Burke, and M S Smyth, and A Otaka, and M Nomizu, and P P Roller, and G Wolf, and R Case, and S E Shoelson
May 2000, Bioorganic & medicinal chemistry letters,
T R Burke, and M S Smyth, and A Otaka, and M Nomizu, and P P Roller, and G Wolf, and R Case, and S E Shoelson
May 2024, Molecular diversity,
Copied contents to your clipboard!